These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9850407)

  • 1. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
    Boisier P; Ramarokoto CE; Ravaoalimalala VE; Rabarijaona L; Serieye J; Roux J; Esterre P
    Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonography in a Senegalese community recently exposed to Schistosoma mansoni infection.
    Kardorff R; Stelma FF; Vocke AK; Yazdanpanah Y; Thomas AK; Mbaye A; Talla I; Niang M; Ehrich JH; Doehring E; Gryseels B
    Am J Trop Med Hyg; 1996 Jun; 54(6):586-90. PubMed ID: 8686776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of praziquantel against Schistosoma mansoni in northern Senegal.
    Picquet M; Vercruysse J; Shaw DJ; Diop M; Ly A
    Trans R Soc Trop Med Hyg; 1998; 92(1):90-3. PubMed ID: 9692165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel.
    Doehring-Schwerdtfeger E; Abdel-Rahim IM; Kardorff R; Kaiser C; Franke D; Schlake J; Richter J; Elsheikh M; Mohamed-Ali Q; Ehrich JH
    Am J Trop Med Hyg; 1992 Apr; 46(4):409-15. PubMed ID: 1575287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographical assessment of morbidity in schistosomiasis mansoni in Madagascar: a community-based study in a rural population.
    Boisier P; Serieye J; Ravaoalimalala VE; Roux J; Esterre P
    Trans R Soc Trop Med Hyg; 1995; 89(2):208-12. PubMed ID: 7778151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
    Frenzel K; Grigull L; Odongo-Aginya E; Ndugwa CM; Loroni-Lakwo T; Schweigmann U; Vester U; Spannbrucker N; Doehring E
    Am J Trop Med Hyg; 1999 Jun; 60(6):927-31. PubMed ID: 10403322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
    Mohamed-Ali Q; Doehring-Schwerdtfeger E; Abdel-Rahim IM; Schlake J; Kardorff R; Franke D; Kaiser C; Elsheikh M; Abdalla M; Schafer P
    Am J Trop Med Hyg; 1991 Apr; 44(4):444-51. PubMed ID: 1904198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
    Rahoud SA; Mergani A; Khamis AH; Saeed OK; Mohamed-Ali Q; Dessein AJ; Elwali NE
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia.
    Berhe N; Myrvang B; Gundersen SG
    Am J Trop Med Hyg; 2008 Feb; 78(2):228-34. PubMed ID: 18256420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters.
    Kardorff R; Gabone RM; Mugashe C; Obiga D; Ramarokoto CE; Mahlert C; Spannbrucker N; Lang A; Günzler V; Gryseels B; Ehrich JH; Doehring E
    Trop Med Int Health; 1997 Mar; 2(3):230-9. PubMed ID: 9491101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schistosomiasis mansoni infection in a hyperendemic region of midwestern Madagascar: epidemiology, morbidity and secondary effects of praziquantel treatment].
    Boisier P; Ravaoalimalala VA; Serieye J; Roux J; Esterre P
    Arch Inst Pasteur Madagascar; 1994; 61(1):43-8. PubMed ID: 7778950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China.
    Li YS; Sleigh AC; Li Y; Tanner M; Dessein A; Williams GM; McManus DP
    Trans R Soc Trop Med Hyg; 2002; 96(4):438-43. PubMed ID: 12497984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
    Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
    East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection.
    Chiavaroli R; Grima P; Grima P
    Infection; 2008 Dec; 36(6):585-9. PubMed ID: 18998054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite.
    Baekby M; Glerup H; Stribolt K; Tarp B
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28814579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of morbidity in hepatosplenic schistosomiasis mansoni after treatment with praziquantel: a long term study.
    Domingues AL; Coutinho AD
    Rev Soc Bras Med Trop; 1990; 23(2):101-7. PubMed ID: 2129517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
    Homeida MA; el Tom I; Nash T; Bennett JL
    Am J Trop Med Hyg; 1991 Sep; 45(3):360-5. PubMed ID: 1928571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.